Want to see XRN full AI Analyst Report?
XRN Stock Chart & Stats
$36.82
-$0.13(-1.62%)
At close: 4:00 PM EST
$36.82
-$0.13(-1.62%)
Day’s Range― - ―
52-Week Range$29.05 - $38.65
Previous CloseN/A
VolumeN/A
Average Volume (3M)117.06K
Market Cap
$439.77M
Enterprise Value$1.38B
Total Cash (Recent Filing)$10.66M
Total Debt (Recent Filing)$636.93M
Price to Earnings (P/E)7.8
Beta0.57
Next Earnings
Nov 04, 2026EPS Estimate
-0.49Next Dividend Ex-DateN/A
Dividend Yield7.05%
Share Statistics
EPS (TTM)3.72
Shares Outstanding13,237,830
10 Day Avg. Volume148,670
30 Day Avg. Volume117,061
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)0.92
Price to Sales (P/S)2.90
P/FCF Ratio-57.89
Enterprise Value/Market Cap3.14
Enterprise Value/Revenue8.80
Enterprise Value/Gross Profit2.27K
Enterprise Value/Ebitda8.71
Forecast
1Y Price Target
$44.00Price Target Upside19.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)2.99
Revenue Forecast (FY)$147.37M
Bulls Say, Bears Say
Bulls Say
Senior Housing PivotThe senior housing pivot is progressing from strategy to operating execution, with acquisitions, resident lease-up activity, and a substantial investment pipeline. Building this platform can diversify the portfolio and create a more focused growth engine over the next several quarters.
Cash GenerationStrong current operating and free cash flow provides internal funding for investment, debt service, and distributions. Although historical consistency is uneven, the present conversion of earnings into cash supports financial resilience while the portfolio transition continues.
Improved Liquidity And LeverageImproved leverage, ample unused credit capacity, and a manageable near-term maturity schedule give management greater flexibility to execute asset recycling and senior housing investments. This reduces immediate refinancing pressure during the repositioning period.
Bears Say
Severe Revenue DeteriorationThe extreme revenue contraction and near-zero gross margin raise substantial questions about the durability of reported profitability. Even with positive current earnings, a weak revenue base can limit operating visibility and make future cash generation less dependable.
Higher Acquisition DebtFunding a major senior housing acquisition with substantial incremental borrowing increases balance-sheet exposure while the new asset is being integrated and leased. Higher debt can constrain future capital allocation and magnify execution risk if expected returns take longer to materialize.
Limited Organic GrowthModest same-store cash NOI growth indicates that existing properties are contributing only limited organic expansion. This places greater reliance on acquisitions, dispositions, and successful lease-ups to drive results, making the repositioning strategy more important to medium-term performance.
Chiron Real Estate ate News
XRN FAQ
What was Chiron Real Estate ate’s price range in the past 12 months?
Chiron Real Estate ate lowest stock price was $29.05 and its highest was $38.65 in the past 12 months.
What is Chiron Real Estate ate’s market cap?
Chiron Real Estate ate’s market cap is $439.77M.
When is Chiron Real Estate ate’s upcoming earnings report date?
Chiron Real Estate ate’s upcoming earnings report date is Nov 04, 2026 which is in 15 days.
How were Chiron Real Estate ate’s earnings last quarter?
Chiron Real Estate ate released its earnings results on Aug 05, 2026. The company reported $4.78 earnings per share for the quarter, beating the consensus estimate of -$0.235 by $5.015.
Is Chiron Real Estate ate overvalued?
According to Wall Street analysts Chiron Real Estate ate’s price is currently Undervalued.
Does Chiron Real Estate ate pay dividends?
Chiron Real Estate ate pays a Monthly dividend of $0.16 which represents an annual dividend yield of 7.05%. See more information on Chiron Real Estate ate dividends here
What is Chiron Real Estate ate’s EPS estimate?
Chiron Real Estate ate’s EPS estimate is -0.49.
How many shares outstanding does Chiron Real Estate ate have?
Chiron Real Estate ate has 13,237,830 shares outstanding.
What happened to Chiron Real Estate ate’s price movement after its last earnings report?
Chiron Real Estate ate reported an EPS of $4.78 in its last earnings report, beating expectations of -$0.235. Following the earnings report the stock price went up 1.14%.
Which hedge fund is a major shareholder of Chiron Real Estate ate?
Currently, no hedge funds are holding shares in XRN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Chiron Real Estate ate Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$44.00 (19.50% Upside)
$44.00 (19.50% Upside)
Blogger Sentiment
Bullish
XRN Sentiment 88%
Sector Average 63%
Sector Average 63%
Hedge Fund Trend
Increased
By 28.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $2.6M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 3.3%
Last 30 Days ▲ 2.2%
Last 30 Days ▲ 2.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-0.95%
12-Months-Change
Fundamentals
Return on Equity
10.77%
Trailing 12-Months
Asset Growth
5.77%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Chiron Real Estate ate
Chiron is a real estate investment trust focused on investing in and actively managing critical healthcare infrastructure. With more than a decade of experience as a public company, it has built a diversified portfolio anchored by strong tenants who deliver essential care in their communities nationwide.
XRN Company Deck
XRN Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a constructive strategic pivot toward senior housing with concrete execution: leadership additions, sizable asset sales and acquisitions, equity issuance, improved liquidity and modest improvement in leverage. At the same time, operating growth is modest, net debt/EBITDAre remains elevated, short-term G&A will rise due to hiring, and there is uncertainty and timing risk around fully monetizing outpatient medical assets and achieving market revaluation. Overall, the company demonstrated meaningful progress and tactical wins but still faces execution and valuation headwinds during the transition.View all XRN earnings summariesXRN Stock 12 Month Forecast
Average Price Target
$44.00
▲(19.50% Upside)
Technical Analysis
Diversified Healthcare Trust
―
Community Healthcare
―
Universal Health Realty Income
―
Strawberry Fields REIT Inc
―
National Healthcare Properties
―
Ownership Overview
1.86% Insiders
24.80% Mutual Funds
0.28% Other Institutional Investors
55.09% Public Companies and
Individual Investors